Treatment GuideJust DiagnosedSex & DatingAfrican AmericanStigmaAsk the HIV DocPrEP En EspañolNewsVoicesPrint IssueVideoOut 100
CONTACTCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2024 Pride Publishing Inc.
All Rights reserved
All Rights reserved
By continuing to use our site, you agree to our Private Policy and Terms of Use.
In a Phase III study, researchers have found that tesamorelin, an analogue of a naturally occurring growth hormone-releasing factor, decreased patients' abdominal fat by 15% on average--compared to a 5% average increase for the placebo group--with minimal side effects. Results were reported in the December 6 issue of The New England Journal of Medicine. A confirmatory trial is ongoing to comply with U.S. Food and Drug Administration regulations. -------------------- Boehringer Ingelheim has reported on a three-year study that has shown protease inhibitor Aptivus, used with ritonavir, provides a superior and durable treatment response for up to three years in HIVers who had previously been treated with antiretrovirals and displayed drug resistance. -------------------- Reporting 48-week data from a Phase III clinical trial, Gilead Sciences says patients who switched from Combivir to Truvada, both in combination with Sustiva, experienced improvements in a number of treatment-related side effects, including lipoatrophy. -------------------- Studies find that antiherpes medication valacyclovir significantly reduces rectal and plasma HIV levels in study participants coinfected with HIV-1 and HSV-2. Researchers conclude, in a report in the November 15 edition of The Journal of Infectious Diseases, that herpes simplex virus suppression might provide clinical benefits to people not receiving antiretroviral therapy. -------------------- From 2000 to 2006, public and philanthropic funding for HIV vaccine and microbicide research and development almost tripled, according to a report released in December by the HIV Vaccines and Microbicides Resource Tracking Working Group, a watchdog organization. The total global investment in preventive vaccine R&D in 2006 was about $933 million, a 23% increase over 2005 levels. Microbicide R&D during the same year reached a worldwide investment of about $222 million, a 35% increase. Between 2000 and 2006, five public-sector funders and two foundations provided $183.6 million for research and development in support of new prevention options, the report found. -------------------- HIVers with CD4-cell counts of 200 or lower who use protease inhibitor Crixivan have complications with dry skin more often than participants in a study who had higher CD4 counts or who were HIV-negative, according to research reported in the October 2007 issue of the journal AIDS. -------------------- Gilead Sciences says a second late-stage trial has shown that its anti-HIV medication Viread was more effective in treating hepatitis B than Hepsera, another Gilead , which is already approved for treating liver infection in adults.
Want more breaking equality news & trending entertainment stories?
Check out our NEW 24/7 streaming service: the Advocate Channel!
Download the Advocate Channel App for your mobile phone and your favorite streaming device!
From our Sponsors
Most Popular
Before AIDS, gay artist Rex drew hot men on the prowl — then he disappeared
April 11 2024 3:15 PM
Diets that mimic fasting reverse aging: study
March 07 2024 5:28 PM
The Most Amazing HIV Allies & Advocates of 2023
November 03 2023 12:51 PM
PrEP without a prescription now a reality in California
February 06 2024 8:37 PM
This OnlyFans Star Is Trying to Raise $100K to Fight HIV
December 26 2023 3:05 PM
Injectable HIV treatment, prevention: Everything you need to know
March 26 2024 3:28 PM
The naked Black body takes center stage in this HIV campaign
January 03 2024 1:07 PM
8 dating tips for gay men from a gay therapist
March 21 2024 2:50 PM
Mr. Gay World wants to make sure you're OK
January 02 2024 4:56 PM
Plus: Featured Video
Latest Stories
The government failed on mpox. Ritchie Torres's new bill addresses that
April 18 2024 1:21 PM
On Anal Sex Day, crack up with The Bottom's Digest
April 18 2024 10:22 AM
Todrick Hall has long supported the communities he comes from
April 17 2024 12:02 PM
Our May/June issue of Plus is here!
April 17 2024 12:00 PM
Giselle Byrd is taking center stage — and helping others do the same
April 10 2024 2:24 PM
Discover endless fun at The Pride Store: Games & electronics for all ages
April 09 2024 4:25 PM
Mean Girls' Daniel Franzese on playing an HIV+ character
April 09 2024 3:57 PM
HIV-positive Air Force, Navy servicemembers victorious in lawsuit
April 09 2024 3:02 PM
Unlocking a new level of beauty with Dr Botanicals' ethical skincare line
April 08 2024 3:40 PM
Unleash your wild side with The Pride Store’s beginner’s guide to kink
April 08 2024 3:35 PM
Why are mpox cases in the U.S. on the rise again?
April 08 2024 1:30 PM
Happy national foreskin day!
April 04 2024 1:45 PM
Adult entertainment icons Derek Kage & Cody Silver lead fight for free speech
April 03 2024 3:06 PM
LGBTQ+ patients twice as likely to face discrimination: survey
April 02 2024 4:57 PM
Spring into The Pride Store’s top new arrivals for April
April 02 2024 4:39 PM
Nashville PD Must Pay HIV-Positive Man Denied a Job
April 01 2024 6:22 PM
Common has a message on how to foster self-love
March 29 2024 7:33 PM
Listen to Dr. Levine: Take syphilis seriously
March 28 2024 6:40 PM
Breaking boundaries in gender-free fashion with Stuzo Clothing
March 27 2024 2:15 PM